In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

ESC in Japan @ JCS 2022 together with APSC 2022

11/03/2022 09:00 13/03/2022 09:00 Europe/Paris ESC in Japan @ JCS 2022 together with APSC 2022

Access event page

Japanese Circulation Society contact@escardio.org DD/MM/YYYY
Online
event

Summary

The ESC is honoured to participate in the 86th Annual Scientific Meeting of the Japanese Circulation Society jointly organised with the Asian Pacific Society of Cardiology (APSC).

In close collaboration with the Japanese Circulation Society, the ESC brings highlights in key topics from ESC Congress 2021 - The Digital Experience to Japan delegates as part of the Final Programme, with three joint scientific sessions.



The 86th Annual Scientific Meeting of the Japanese Circulation Society (JCS2022) will be held online from 11 to 13 March 2022 together with the Asian Pacific Society of Cardiology (APSC).

For more information, visit the Congress web site.

A long lasting relationship

achenbach-stephan-2019-congress-news.jpgThe ESC is honoured to be invited to the Opening Ceremony of the Japanese Circulation Society where the ESC President, Stephan Achenbach, will deliver a recorded message.

 

 

Friday 11 March 2022

ESC/JCS Symposium 1 - Heart failure with preserved ejection fraction an update

Chairpersons

Michel Komajda (France), Ichiro Shiojima (Japan)

17:45-19:15 JST / 09:45-11:15 CET
17:45-18:00 JST / 09:45-10:00 CET Pathophysiology Hiroshi Akazawa (Japan)
18:00-18:07 JST / 10:00-10:07 CET Discussion  
18:07-18:22 JST / 10:07-10:22 CET Diagnostic challenges ESC Speaker
18:22-18:29 JST / 10:22-10:29 CET Discussion  
18:29-18:44 JST / 10:29-10:44 CET Pharmacological approach Michel Komajda (France)
18:44-18:51 JST / 10:44-10:51 CET Discussion  
18:51-19:06 JST / 10:51-11:06 CET Nonpharmacological approach Yasushi Sakata (Japan)
19:06-19:13 JST / 11:06-11:13 CET Discussion  

Saturday 12 March 2022

ESC/JCS Symposium 2 - Cardiovascular prevention: what is new?

Chairpersons

Diederick Grobbee (The Netherlands), Koichi Node (Japan)

17:45-19:15 JST / 09:45-11:15 CET
17:45-18:00 JST / 09:45-10:00 CET Salt restriction /substitution in primary prevention Diederick Grobbee (The Netherlands)
18:00-18:07 JST / 10:00-10:07 CET Discussion  
18:07-18:22 JST / 10:07-10:22 CET Threshold of blood pressure control in primary prevention: any new evidence? Kazuomi Kario (Japan)
18:22-18:29 JST / 10:22-10:29 CET Discussion  
18:29-18:44 JST / 10:29-10:44 CET Non-conventional risk factors in primary prevention François Mach (Switzerland)
18:44-18:51 JST / 10:44-10:51 CET Discussion  
18:51-19:06 JST / 10:51-11:06 CET Risk estimation and ethnicity Yoshihiro Fukumoto (Japan)
19:06-19:13 JST / 11:06-11:13 CET Discussion  

Sunday 13 March 2022

ESC/JCS Official Joint Symposium: Case Discussions with the Masters in Japan and Europe: Interventions of Mitral or Tricuspid valve 

Chairpersons

Stephan Achenbach (Germany), Yoshihiro Morino (Japan)

15:30-17:00 JST / 07:30-09:00 CET
15:30-15:35 JST / 07:30-07:35 CET Current status of Interventions of Mitral or Tricuspid valve in Japan: Overall introduction Yoshihiro Morino (Japan)
15:35-15:40 JST / 07:35-07:40 CET Current status of Interventions of Mitral or Tricuspid valve in Europe: Overall introduction Stephan Achenbach (Germany)
15:40-15:58 JST / 07:40-07:58 CET Transcatheter mitral valve repair vs surgery: the results Fabien Praz (Switzerland)
15:58-16:03 JST / 07:58-08:03 CET Discussions  
16:03-16:21 JST / 08:03-08:21 CET Challenging cases of Mitralclip for functional and degenerative regurgitation Mike Saji (Japan)
16:21-16:26 JST / 08:21-08:26 CET Discussions  
16:26-16:38 JST / 08:26-08:38 CET Tricuspid regurgitation: medical, surgical or transcatheter treatment? Nicole Karam (France)
16:38-16:43 JST / 08:38-08:43 CET Discussions  
16:43-16:55 JST / 08:43-08:55 Tricuspid intervention for congenital abnormality Yoshifumi Nakajima (Japan)
16:55-17:00 JST / 08:55-09:00 CET Discussions  

Connect with the ESC

Create your My ESC Account – your gateway to the ESC. It’s free and available in a few short clicks! Want regular updates on ESC science, tools and congresses and education?

Subscribe to our newsletters.

About the European Society of Cardiology

The ESC is the world’s largest organisation of healthcare professionals dedicated to fighting heart disease. It helps more than 100,000 clinicians, scientists, nurses and allied professionals expand the boundaries of cardiovascular medicine.

The ESC publishes scientific journals, an array of textbooks and world renowned ESC Clinical Practice Guidelines. It provides continuing medical education through webinars and classroom courses, and hosts the summit of cardiovascular science each August - ESC Congress - which attracts more than 32,000 heart specialists.

Join our community of cardiologists from more than 150 countries - Become an ESC Professional Member.